Form preview

Get the free label. Kadcyla (Ado- emtansine), Genentech, Inc.

Get Form
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use KAYLA safely and effectively. See full prescribing information for KAYLA. KAYLA (adotrastuzumab
We are not affiliated with any brand or entity on this form
4,4
98,753 Reviews
4,5
11,210 Reviews
4,6
715 Reviews
4,6
789 Reviews

Get, Create, Make and Sign label kadcyla ado- emtansine

Edit
Edit your label kadcyla ado- emtansine form online
Type text, complete fillable fields, insert images, highlight or blackout data for discretion, add comments, and more.
Add
Add your legally-binding signature
Draw or type your signature, upload a signature image, or capture it with your digital camera.
Share
Share your form instantly
Email, fax, or share your label kadcyla ado- emtansine form via URL. You can also download, print, or export forms to your preferred cloud storage service.

Editing label kadcyla ado- emtansine online

9.5
Ease of Setup
pdfFiller User Ratings on G2
9.0
Ease of Use
pdfFiller User Ratings on G2
Here are the steps you need to follow to get started with our professional PDF editor:
1
Create an account. Begin by choosing Start Free Trial and, if you are a new user, establish a profile.
2
Simply add a document. Select Add New from your Dashboard and import a file into the system by uploading it from your device or importing it via the cloud, online, or internal mail. Then click Begin editing.
3
Edit label kadcyla ado- emtansine. Rearrange and rotate pages, add new and changed texts, add new objects, and use other useful tools. When you're done, click Done. You can use the Documents tab to merge, split, lock, or unlock your files.
4
Get your file. Select the name of your file in the docs list and choose your preferred exporting method. You can download it as a PDF, save it in another format, send it by email, or transfer it to the cloud.

Uncompromising security for your PDF editing and eSignature needs

Your private information is safe with pdfFiller. We employ end-to-end encryption, secure cloud storage, and advanced access control to protect your documents and maintain regulatory compliance.
Learn more about security & compliance
GDPR
AICPA SOC 2
PCI
HIPAA
CCPA
FDA

How to fill out label kadcyla ado- emtansine

Illustration

How to fill out label kadcyla ado- emtansine

01
Begin by reading the instructions on the label of Kadcyla (ado-trastuzumab emtansine) carefully.
02
Prepare a clean and dry surface to work on.
03
Take out the Kadcyla vial from the refrigerator and allow it to reach room temperature.
04
Gather the necessary supplies, including a syringe, needle, and alcohol swabs.
05
Clean the rubber stopper on the Kadcyla vial with an alcohol swab.
06
Use the syringe to withdraw the required amount of Kadcyla as directed by your healthcare provider.
07
If necessary, mix the Kadcyla with a compatible diluent according to the instructions.
08
Gently swirl the vial to ensure proper mixing, but do not shake vigorously.
09
Check the vial for any visible particles or discoloration. If present, do not use it and contact your healthcare provider.
10
Attach the appropriate needle to the syringe.
11
Remove any air bubbles from the syringe by tapping it and pushing the plunger slightly.
12
Administer the Kadcyla injection as instructed by your healthcare provider, following proper injection technique.
13
Dispose of any unused medication and used syringes/needles safely according to local regulations.
14
Wash your hands thoroughly after handling Kadcyla.

Who needs label kadcyla ado- emtansine?

01
Kadcyla (ado-trastuzumab emtansine) is a medication primarily used for the treatment of HER2-positive breast cancer.
02
Patients who have been diagnosed with HER2-positive breast cancer may be candidates for Kadcyla.
03
It is typically prescribed when other standard treatments, such as trastuzumab or chemotherapy, have not been effective.
04
However, it is important to consult with a healthcare provider who can assess individual patient needs and determine if Kadcyla is appropriate.
05
The decision to use Kadcyla is made on a case-by-case basis.
Fill form : Try Risk Free
Users Most Likely To Recommend - Summer 2025
Grid Leader in Small-Business - Summer 2025
High Performer - Summer 2025
Regional Leader - Summer 2025
Easiest To Do Business With - Summer 2025
Best Meets Requirements- Summer 2025
Rate the form
4.6
Satisfied
42 Votes

For pdfFiller’s FAQs

Below is a list of the most common customer questions. If you can’t find an answer to your question, please don’t hesitate to reach out to us.

You can easily create your eSignature with pdfFiller and then eSign your label kadcyla ado- emtansine directly from your inbox with the help of pdfFiller’s add-on for Gmail. Please note that you must register for an account in order to save your signatures and signed documents.
You may do so effortlessly with pdfFiller's iOS and Android apps, which are available in the Apple Store and Google Play Store, respectively. You may also obtain the program from our website: https://edit-pdf-ios-android.pdffiller.com/. Open the application, sign in, and begin editing label kadcyla ado- emtansine right away.
You can quickly make and fill out legal forms with the help of the pdfFiller app on your phone. Complete and sign label kadcyla ado- emtansine and other documents on your mobile device using the application. If you want to learn more about how the PDF editor works, go to pdfFiller.com.
Label kadcyla ado-emtansine is a medication used to treat certain types of breast cancer. It is also known as T-DM1 or trastuzumab emtansine.
Manufacturers or distributors of label kadcyla ado-emtansine are required to file the label with the appropriate regulatory authorities.
The label for kadcyla ado-emtansine should include information about the drug's composition, indications, dosages, contraindications, and side effects.
The purpose of the label for kadcyla ado-emtansine is to provide healthcare professionals and patients with important information about the medication.
The label for kadcyla ado-emtansine must include information about the drug's composition, indications, dosages, contraindications, and side effects.
Fill out your label kadcyla ado- emtansine online with pdfFiller!

pdfFiller is an end-to-end solution for managing, creating, and editing documents and forms in the cloud. Save time and hassle by preparing your tax forms online.

Get started now
Form preview

Label Kadcyla Ado- Emtansine is not the form you're looking for?Search for another form here.

Related Features

Paste Letter in FDX with ease
Replace Line in STW with ease
Replace Table in Doc with ease
Replace Table in Docx with ease
Replace Table in Jpeg with ease

Relevant keywords

2000 2014 kadcyla emtansine dm1 thrombocytopenia her2 transaminases lvef ci pfs uln hepatotoxicity mm3 pharmacokinetics nrh pneumonitis cyp3a4 genentech pharmacokinetic neurotoxicity mcc microtubule stratified clcr adrs

Related Forms

Form preview
suing
United states patent and trademark office commissioner for patents united states patent and trademark office
Fill Now
Form preview
form imm 5406
Pto/sb/94 (02-09) approved for use through 02/29/2012. omb 0651-0036 u.s. patent and trademark office; u.s.
Fill Now
Form preview
uspto customer number lookup
Pto/sb/125a (11-08) approved for use through 11/30/2011. omb 0651-0035 u.s. patent and trademark office, u.s.
Fill Now
Form preview
suspto
Doc code: .req.rear pto/sb/38 (07-09) approved for use through 07/31/2012. omb 0651-0031 u.s. patent and
Fill Now
Form preview
can i email an applicant initiated interview request form
Find fillablearmytarptrainingcertificatejobs at
Fill Now
Form preview
REQUEST FOR ACCESS TO AN ABANDONED APPLICATION ... - uspto
Pto/sb/68 (02-10) approved for use through 07/31/2012. omb 0651-0031 u.s. patent and trademark office; u.s.
Fill Now
If you believe that this page should be taken down, please follow our DMCA take down process here .
This form may include fields for payment information. Data entered in these fields is not covered by PCI DSS compliance.